The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma
Clinical trial NCT03830606 · COMPLETED
Trial details
- NCT number
- NCT03830606
- Sponsor
- Aiping Zhou
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-23
- Primary completion
- 2018-09-02
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.